查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813513

癌症免疫治疗市场分析及预测（至2034年）：类型、产品、技术、应用、最终用户、模式、阶段、功能和解决方案

Cancer Immunotherapy Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Mode, Stage, Functionality, Solutions
出版日期: | 出版商: Global Insight Services | 英文 356 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计癌症免疫疗法市场规模将从2024年的2,286亿美元增加到2034年的5,423亿美元，复合年增长率约为9%。癌症免疫疗法市场涵盖单株抗体、查核点抑制剂和癌症疫苗等疗法，旨在利用和增强免疫系统的天然抗癌能力。技术进步、癌症发生率的上升以及对个人化医疗日益增长的关注推动着这一市场的发展。创新旨在提高疗效、减少副作用并实现持久疗效，从而推动研究和临床试验，以扩展治疗应用。

在个人化医疗和标靶治疗的推动下，癌症免疫治疗市场正在经历强劲成长。单株抗体市场由于其针对癌细胞的特异性和有效性而处于领先地位。查核点抑制剂可以增强免疫系统对抗癌症的能力，也正在成为表现第二好的市场。自我调整细胞疗法，包括 CAR-T 细胞疗法，正在成为创新方法，并显示出巨大的未来应用前景。疫苗，特别是治疗性癌症疫苗，由于其预防癌症復发的潜力而引起越来越多的关注。细胞细胞激素虽然不那么占主导地位，但在增强免疫反应方面仍发挥辅助作用。生物标记和伴随诊断的整合正在提高治疗的精确度并进一步推动市场扩张。持续的研究和发展以及策略伙伴关係对于在这个充满活力的环境中释放新机会和确保持续成长和创新至关重要。

市场区隔
类型 单株抗体、查核点抑制剂、癌症疫苗、细胞激素、自我调整细胞疗法、癌细胞疗法、双特异性抗体、免疫查核点调变器
产品 治疗性抗体、免疫系统调变器、细胞疗法、查核点抑制、癌症疫苗、溶瘤病毒、细胞激素
科技 基因编辑、CRISPR、CAR-T细胞疗法、TCR疗法、单株抗体技术、奈米技术、双特异性抗体技术
目的 肺癌、乳癌、结肠癌、黑色素瘤、摄护腺癌、白血病、淋巴瘤
最终用户 医院、癌症研究机构、诊所、生物製药公司、学术研究机构
剂型 静脉注射、口服、皮下及肌肉注射
阶段 临床试验、商业化、临床前
功能 免疫活化、免疫抑制、免疫调节
解决方案 个人化免疫治疗、联合治疗与标靶治疗

市场概述

癌症免疫治疗市场充满活力，创新定价策略和新疗法的推出导致市场份额波动。不断推出的新产品正在重塑竞争格局，并为成长和发展创造环境。各公司正在策略性地定位自己，利用其先进的研发能力抓住新机会。旨在提高治疗效果和扩大市场范围的策略联盟和伙伴关係进一步推动了这一势头。在竞争激烈的舞台上，主要企业正在进行严格的基准基准化分析，以保持竞争优势。监管影响起着关键作用，严格的指导方针决定市场进入和永续性。全球监管格局多种多样，北美和欧洲设定了影响全球标准的严格基准。由于有利的监管改革和不断增加的医疗保健投资，亚太地区正在成为一个利润丰厚的市场。竞争和监管之间的相互作用正在塑造癌症免疫治疗市场的发展轨迹，为创新和成长提供了沃土。

主要趋势和驱动因素：

由于技术进步和研发投入的增加，癌症免疫治疗市场正经历强劲成长。主要趋势包括开发针对个别患者情况的个人化免疫疗法，以提高治疗效果。联合治疗的兴起也是一个重要趋势，它整合多种治疗方法来改善治疗效果。此外，对肿瘤微环境的日益了解也推动了标靶治疗的创新。监管支持的增加和核准流程的加速正在加速新型疗法的市场进入。驱动因素包括全球癌症发生率的上升和对更有效治疗方法的未满足需求。医疗专业人员和患者对免疫疗法的认识和接受度的提高也是市场发展的动力。在医疗保健基础设施完善、对先进疗法的需求不断增长的新兴市场，治疗机会丰富。投资于最尖端科技和策略合作伙伴关係的公司能够充分利用这些趋势，确保癌症免疫治疗市场的持续成长。

阻碍因素与挑战：

癌症免疫疗法市场面临几个重大的限制和挑战。其中一个主要挑战是治疗费用高昂，这限制了许多患者获得治疗的机会，并给医疗保健系统带来了经济负担。这些治疗方法通常需要在研发方面投入大量资金，因此价格高昂。监理挑战也十分严峻。新型免疫疗法的严格核准程序延迟了市场进入并增加了成本。此外，癌症免疫疗法的复杂机制使其难以预测患者的反应，导致治疗结果参差不齐。另一个挑战是用于选择患者的生物标记有限。这限制了识别最能从特定治疗方法中受益的患者的能力，从而导致治疗效果降低。此外，市场也面临化疗和放射线治疗等更成熟、更广泛接受的传统癌症治疗方法的竞争。最后，需要提高公众和专业人士的认识。对免疫疗法潜在益处缺乏了解可能会阻碍其采用和融入标准护理。

主要企业

Adaptimmune Therapeutics、Immunocore、Iovance Biotherapeutics、Fate Therapeutics、Kite Pharma、Jounce Therapeutics、Replimune Group、Compugen、Agenus、OncoSec Medical、CureVac、Neon Therapeutics、BioNTech、Tessa Therapeutics、Argenx

目录

第 1 章：癌症免疫治疗市场概述

  • 调查目的
  • 癌症免疫疗法市场定义和范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章：癌症免疫治疗市场展望

  • 癌症免疫治疗市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章：癌症免疫治疗市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章 癌症免疫治疗市场规模

  • 癌症免疫治疗市场规模（按价值）
  • 癌症免疫治疗市场规模

第七章 癌症免疫治疗市场（按类型）

  • 市场概况
  • 单株抗体
  • 查核点抑制剂
  • 癌症疫苗
  • 细胞激素
  • 自我调整细胞疗法
  • 癌细胞治疗
  • 双特异性抗体
  • 免疫查核点调变器
  • 其他的

第八章 癌症免疫治疗市场（按产品）

  • 市场概况
  • 治疗性抗体
  • 免疫系统调变器
  • 细胞疗法
  • 查核点抑制
  • 癌症疫苗
  • 溶瘤病毒
  • 细胞激素
  • 其他的

第九章 癌症免疫治疗市场（依技术）

  • 市场概况
  • 基因编辑
  • CRISPR
  • CAR-T细胞疗法
  • TCR疗法
  • 单株抗体技术
  • 奈米科技
  • 双特异性抗体技术
  • 其他的

第 10 章癌症免疫治疗市场（按应用）

  • 市场概况
  • 肺癌
  • 乳癌
  • 大肠直肠癌
  • 黑色素瘤
  • 摄护腺癌
  • 白血病
  • 淋巴瘤
  • 其他的

第 11 章 癌症免疫治疗市场（按最终用户）

  • 市场概况
  • 医院
  • 癌症研究所
  • 诊所
  • 生物製药公司
  • 学术研究机构
  • 其他的

第十二章 癌症免疫治疗市场（按模式）

  • 市场概况
  • 静脉注射
  • 口服
  • 皮下给药
  • 肌肉注射
  • 其他的

第十三章 癌症免疫治疗市场（依阶段）

  • 市场概况
  • 临床试验
  • 商业化
  • 临床前
  • 其他的

第十四章 癌症免疫治疗市场（依功能）

  • 市场概况
  • 免疫活化
  • 免疫抑制
  • 免疫调节
  • 其他的

第十五章 癌症免疫治疗市场（依解决方案）

  • 市场概况
  • 个人化免疫疗法
  • 联合治疗
  • 标靶治疗
  • 其他的

第十六章 癌症免疫治疗市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章：公司简介

  • Adaptimmune Therapeutics
  • Immunocore
  • Iovance Biotherapeutics
  • Fate Therapeutics
  • Kite Pharma
  • Jounce Therapeutics
  • Replimune Group
  • Compugen
  • Agenus
  • OncoSec Medical
  • CureVac
  • Neon Therapeutics
  • BioNTech
  • Tessa Therapeutics
  • Argenx
简介目录
Product Code: GIS33693

Cancer Immunotherapy Market is anticipated to expand from $228.6 billion in 2024 to $542.3 billion by 2034, growing at a CAGR of approximately 9%. The Cancer Immunotherapy Market encompasses treatments that harness and enhance the innate powers of the immune system to combat cancer, including monoclonal antibodies, checkpoint inhibitors, and cancer vaccines. This market is driven by technological advancements, a rising prevalence of cancer, and an increasing focus on personalized medicine. Innovations aim to improve efficacy, reduce side effects, and offer durable responses, with a strong emphasis on research and clinical trials to expand therapeutic applications.

The Cancer Immunotherapy Market is experiencing robust growth, propelled by advancements in personalized medicine and targeted therapies. The monoclonal antibodies segment leads in performance, owing to their specificity and effectiveness in targeting cancer cells. Checkpoint inhibitors, which enhance the immune system's ability to fight cancer, are also gaining prominence as the second highest performing segment. Adoptive cell transfer therapies, including CAR-T cell therapies, are emerging as a transformative approach, offering substantial promise for future applications. Vaccines, particularly therapeutic cancer vaccines, are witnessing increased interest due to their potential to prevent cancer recurrence. Cytokines, although less dominant, continue to play a supportive role in boosting immune responses. The integration of biomarkers and companion diagnostics is enhancing treatment precision, driving further market expansion. Continuous research and development, coupled with strategic collaborations, are pivotal in unlocking new opportunities within this dynamic landscape, ensuring sustained growth and innovation.

Market Segmentation
TypeMonoclonal Antibodies, Checkpoint Inhibitors, Cancer Vaccines, Cytokines, Adoptive Cell Therapy, Oncolytic Virus Therapy, Bispecific Antibodies, Immune Checkpoint Modulators
ProductTherapeutic Antibodies, Immune System Modulators, Cell Therapies, Checkpoint Blockade, Cancer Vaccines, Oncolytic Viruses, Cytokines
TechnologyGene Editing, CRISPR, CAR-T Cell Therapy, TCR Therapy, Monoclonal Antibody Technology, Nanotechnology, Bi-specific Antibody Technology
ApplicationLung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Leukemia, Lymphoma
End UserHospitals, Cancer Research Institutes, Clinics, Biopharmaceutical Companies, Academic and Research Institutes
ModeIntravenous, Oral, Subcutaneous, Intramuscular
StageClinical Trials, Commercialized, Preclinical
FunctionalityImmune Activation, Immune Suppression, Immune Modulation
SolutionsPersonalized Immunotherapy, Combination Therapies, Targeted Therapy

Market Snapshot:

The Cancer Immunotherapy Market is witnessing a dynamic landscape with a significant shift in market share, driven by innovative pricing strategies and the introduction of novel therapies. The continuous influx of new product launches is reshaping the competitive scenario, fostering an environment ripe for growth and development. Companies are strategically positioning themselves to capture emerging opportunities by leveraging advanced research and development capabilities. This momentum is further propelled by strategic collaborations and partnerships aimed at enhancing therapeutic efficacy and expanding market reach. In the competitive arena, key players are engaging in rigorous benchmarking to maintain their competitive edge. Regulatory influences play a pivotal role, with stringent guidelines dictating market entry and sustainability. The global landscape is characterized by a diverse regulatory framework, with North America and Europe setting stringent benchmarks that influence global standards. Asia-Pacific is emerging as a lucrative market, driven by favorable regulatory reforms and increased healthcare investments. The interplay of competition and regulation shapes the trajectory of the Cancer Immunotherapy Market, offering a fertile ground for innovation and growth.

Geographical Overview:

The cancer immunotherapy market is flourishing globally, with notable regional distinctions. North America leads, driven by substantial R&D investments and a high prevalence of cancer cases. The region's advanced healthcare infrastructure and robust biotech industry further propel market growth. Europe follows, with strong governmental support for cancer research and increasing adoption of innovative therapies. The region's focus on personalized medicine enhances its market position. In Asia Pacific, rapid expansion is observed, fueled by rising cancer incidences and growing healthcare expenditures. Countries like China and India emerge as key growth pockets, investing heavily in biotechnology and healthcare advancements. Latin America and the Middle East & Africa present promising opportunities. In these regions, increasing awareness and improving healthcare systems foster growth. Brazil and South Africa, in particular, are witnessing significant investments in cancer treatment infrastructure, recognizing the potential of immunotherapy in improving patient outcomes. These emerging markets are poised for substantial expansion in the coming years.

Key Trends and Drivers:

The Cancer Immunotherapy Market is experiencing robust growth fueled by technological advancements and increased investment in research and development. Key trends include the development of personalized immunotherapies tailored to individual patient profiles, enhancing treatment efficacy. The rise of combination therapies is another significant trend, offering improved outcomes by integrating multiple modalities. Furthermore, the expanding understanding of tumor microenvironments is driving innovation in targeted therapies. Increased regulatory support and expedited approval processes are accelerating market entry for novel treatments. Drivers include the growing prevalence of cancer worldwide and the unmet need for more effective therapies. Additionally, the market is benefiting from heightened awareness and acceptance of immunotherapy among healthcare providers and patients. Opportunities abound in emerging markets where healthcare infrastructure is improving, and demand for advanced treatments is rising. Companies investing in cutting-edge technologies and strategic collaborations are well-positioned to capitalize on these trends, ensuring sustained growth in the Cancer Immunotherapy Market.

Restraints and Challenges:

The cancer immunotherapy market encounters several significant restraints and challenges. One primary challenge is the high cost of treatment, which limits accessibility for many patients and places a financial burden on healthcare systems. These therapies often require substantial investment in research and development, leading to elevated prices. Regulatory hurdles also pose a significant challenge. The rigorous approval processes for new immunotherapies can delay market entry and increase costs. Furthermore, the complexity of cancer immunotherapy mechanisms makes it difficult to predict patient responses, leading to variable treatment outcomes. Another challenge is the limited availability of biomarkers for patient selection. This limits the ability to identify individuals who would benefit most from specific therapies, reducing treatment efficacy. Additionally, the market faces competition from traditional cancer treatments, such as chemotherapy and radiation, which are more established and widely accepted. Finally, there is a need for better public and professional awareness. The lack of understanding about immunotherapy's potential benefits can hinder its adoption and integration into standard care practices.

Key Players:

Adaptimmune Therapeutics, Immunocore, Iovance Biotherapeutics, Fate Therapeutics, Kite Pharma, Jounce Therapeutics, Replimune Group, Compugen, Agenus, OncoSec Medical, CureVac, Neon Therapeutics, BioNTech, Tessa Therapeutics, Argenx

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Cancer Immunotherapy Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Cancer Immunotherapy Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Mode
  • 2.9 Key Highlights of the Market, by Stage
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Mode
  • 3.8 Market Attractiveness Analysis, by Stage
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Cancer Immunotherapy Market Outlook

  • 4.1 Cancer Immunotherapy Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Cancer Immunotherapy Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Cancer Immunotherapy Market Size

  • 6.1 Cancer Immunotherapy Market Size, by Value
  • 6.2 Cancer Immunotherapy Market Size, by Volume

7: Cancer Immunotherapy Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Checkpoint Inhibitors
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Cancer Vaccines
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Cytokines
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Adoptive Cell Therapy
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Oncolytic Virus Therapy
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Bispecific Antibodies
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Immune Checkpoint Modulators
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Cancer Immunotherapy Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Antibodies
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Immune System Modulators
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Cell Therapies
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Checkpoint Blockade
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Cancer Vaccines
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Oncolytic Viruses
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Cytokines
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Others
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region

9: Cancer Immunotherapy Market, by Technology

  • 9.1 Market Overview
  • 9.2 Gene Editing
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 CRISPR
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 CAR-T Cell Therapy
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 TCR Therapy
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Monoclonal Antibody Technology
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Nanotechnology
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Bi-specific Antibody Technology
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Others
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region

10: Cancer Immunotherapy Market, by Application

  • 10.1 Market Overview
  • 10.2 Lung Cancer
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Breast Cancer
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Colorectal Cancer
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Melanoma
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Prostate Cancer
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Leukemia
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Lymphoma
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region
  • 10.9 Others
    • 10.9.1 Key Market Trends & Opportunity Analysis
    • 10.9.2 Market Size and Forecast, by Region

11: Cancer Immunotherapy Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cancer Research Institutes
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Clinics
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Biopharmaceutical Companies
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Academic and Research Institutes
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: Cancer Immunotherapy Market, by Mode

  • 12.1 Market Overview
  • 12.2 Intravenous
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Oral
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Subcutaneous
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Intramuscular
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Cancer Immunotherapy Market, by Stage

  • 13.1 Market Overview
  • 13.2 Clinical Trials
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Commercialized
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Preclinical
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Cancer Immunotherapy Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Immune Activation
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Immune Suppression
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Immune Modulation
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Cancer Immunotherapy Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Personalized Immunotherapy
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Combination Therapies
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Targeted Therapy
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Cancer Immunotherapy Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Technology
    • 16.2.5 North America Market Size and Forecast, by Application
    • 16.2.6 North America Market Size and Forecast, by End User
    • 16.2.7 North America Market Size and Forecast, by Mode
    • 16.2.8 North America Market Size and Forecast, by Stage
    • 16.2.9 North America Market Size and Forecast, by Functionality
    • 16.2.10 North America Market Size and Forecast, by Solutions
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Technology
      • 16.2.9.4 United States Market Size and Forecast, by Application
      • 16.2.9.5 United States Market Size and Forecast, by End User
      • 16.2.9.6 United States Market Size and Forecast, by Mode
      • 16.2.9.7 United States Market Size and Forecast, by Stage
      • 16.2.9.8 United States Market Size and Forecast, by Functionality
      • 16.2.9.9 United States Market Size and Forecast, by Solutions
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Technology
      • 16.2.10.4 Canada Market Size and Forecast, by Application
      • 16.2.10.5 Canada Market Size and Forecast, by End User
      • 16.2.10.6 Canada Market Size and Forecast, by Mode
      • 16.2.10.7 Canada Market Size and Forecast, by Stage
      • 16.2.10.8 Canada Market Size and Forecast, by Functionality
      • 16.2.10.9 Canada Market Size and Forecast, by Solutions
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Technology
    • 16.3.5 Europe Market Size and Forecast, by Application
    • 16.3.6 Europe Market Size and Forecast, by End User
    • 16.3.7 Europe Market Size and Forecast, by Mode
    • 16.3.8 Europe Market Size and Forecast, by Stage
    • 16.3.9 Europe Market Size and Forecast, by Functionality
    • 16.3.10 Europe Market Size and Forecast, by Solutions
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Mode
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Technology
      • 16.3.10.4 Germany Market Size and Forecast, by Application
      • 16.3.10.5 Germany Market Size and Forecast, by End User
      • 16.3.10.6 Germany Market Size and Forecast, by Mode
      • 16.3.10.7 Germany Market Size and Forecast, by Stage
      • 16.3.10.8 Germany Market Size and Forecast, by Functionality
      • 16.3.10.9 Germany Market Size and Forecast, by Solutions
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Technology
      • 16.3.11.4 France Market Size and Forecast, by Application
      • 16.3.11.5 France Market Size and Forecast, by End User
      • 16.3.11.6 France Market Size and Forecast, by Mode
      • 16.3.11.7 France Market Size and Forecast, by Stage
      • 16.3.11.8 France Market Size and Forecast, by Functionality
      • 16.3.11.9 France Market Size and Forecast, by Solutions
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Technology
      • 16.3.12.4 Spain Market Size and Forecast, by Application
      • 16.3.12.5 Spain Market Size and Forecast, by End User
      • 16.3.12.6 Spain Market Size and Forecast, by Mode
      • 16.3.12.7 Spain Market Size and Forecast, by Stage
      • 16.3.12.8 Spain Market Size and Forecast, by Functionality
      • 16.3.12.9 Spain Market Size and Forecast, by Solutions
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Technology
      • 16.3.13.4 Italy Market Size and Forecast, by Application
      • 16.3.13.5 Italy Market Size and Forecast, by End User
      • 16.3.13.6 Italy Market Size and Forecast, by Mode
      • 16.3.13.7 Italy Market Size and Forecast, by Stage
      • 16.3.13.8 Italy Market Size and Forecast, by Functionality
      • 16.3.13.9 Italy Market Size and Forecast, by Solutions
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.4 Netherlands Market Size and Forecast, by Application
      • 16.3.14.5 Netherlands Market Size and Forecast, by End User
      • 16.3.14.6 Netherlands Market Size and Forecast, by Mode
      • 16.3.14.7 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 16.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Technology
      • 16.3.15.4 Sweden Market Size and Forecast, by Application
      • 16.3.15.5 Sweden Market Size and Forecast, by End User
      • 16.3.15.6 Sweden Market Size and Forecast, by Mode
      • 16.3.15.7 Sweden Market Size and Forecast, by Stage
      • 16.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 16.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.4 Switzerland Market Size and Forecast, by Application
      • 16.3.16.5 Switzerland Market Size and Forecast, by End User
      • 16.3.16.6 Switzerland Market Size and Forecast, by Mode
      • 16.3.16.7 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 16.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Technology
      • 16.3.17.4 Denmark Market Size and Forecast, by Application
      • 16.3.17.5 Denmark Market Size and Forecast, by End User
      • 16.3.17.6 Denmark Market Size and Forecast, by Mode
      • 16.3.17.7 Denmark Market Size and Forecast, by Stage
      • 16.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 16.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Technology
      • 16.3.18.4 Finland Market Size and Forecast, by Application
      • 16.3.18.5 Finland Market Size and Forecast, by End User
      • 16.3.18.6 Finland Market Size and Forecast, by Mode
      • 16.3.18.7 Finland Market Size and Forecast, by Stage
      • 16.3.18.8 Finland Market Size and Forecast, by Functionality
      • 16.3.18.9 Finland Market Size and Forecast, by Solutions
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Technology
      • 16.3.19.4 Russia Market Size and Forecast, by Application
      • 16.3.19.5 Russia Market Size and Forecast, by End User
      • 16.3.19.6 Russia Market Size and Forecast, by Mode
      • 16.3.19.7 Russia Market Size and Forecast, by Stage
      • 16.3.19.8 Russia Market Size and Forecast, by Functionality
      • 16.3.19.9 Russia Market Size and Forecast, by Solutions
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Mode
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Mode
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Technology
      • 16.4.9.4 China Market Size and Forecast, by Application
      • 16.4.9.5 China Market Size and Forecast, by End User
      • 16.4.9.6 China Market Size and Forecast, by Mode
      • 16.4.9.7 China Market Size and Forecast, by Stage
      • 16.4.9.8 China Market Size and Forecast, by Functionality
      • 16.4.9.9 China Market Size and Forecast, by Solutions
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Technology
      • 16.4.10.4 India Market Size and Forecast, by Application
      • 16.4.10.5 India Market Size and Forecast, by End User
      • 16.4.10.6 India Market Size and Forecast, by Mode
      • 16.4.10.7 India Market Size and Forecast, by Stage
      • 16.4.10.8 India Market Size and Forecast, by Functionality
      • 16.4.10.9 India Market Size and Forecast, by Solutions
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Technology
      • 16.4.11.4 Japan Market Size and Forecast, by Application
      • 16.4.11.5 Japan Market Size and Forecast, by End User
      • 16.4.11.6 Japan Market Size and Forecast, by Mode
      • 16.4.11.7 Japan Market Size and Forecast, by Stage
      • 16.4.11.8 Japan Market Size and Forecast, by Functionality
      • 16.4.11.9 Japan Market Size and Forecast, by Solutions
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Technology
      • 16.4.12.4 South Korea Market Size and Forecast, by Application
      • 16.4.12.5 South Korea Market Size and Forecast, by End User
      • 16.4.12.6 South Korea Market Size and Forecast, by Mode
      • 16.4.12.7 South Korea Market Size and Forecast, by Stage
      • 16.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 16.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Technology
      • 16.4.13.4 Australia Market Size and Forecast, by Application
      • 16.4.13.5 Australia Market Size and Forecast, by End User
      • 16.4.13.6 Australia Market Size and Forecast, by Mode
      • 16.4.13.7 Australia Market Size and Forecast, by Stage
      • 16.4.13.8 Australia Market Size and Forecast, by Functionality
      • 16.4.13.9 Australia Market Size and Forecast, by Solutions
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Technology
      • 16.4.14.4 Singapore Market Size and Forecast, by Application
      • 16.4.14.5 Singapore Market Size and Forecast, by End User
      • 16.4.14.6 Singapore Market Size and Forecast, by Mode
      • 16.4.14.7 Singapore Market Size and Forecast, by Stage
      • 16.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 16.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.4 Indonesia Market Size and Forecast, by Application
      • 16.4.15.5 Indonesia Market Size and Forecast, by End User
      • 16.4.15.6 Indonesia Market Size and Forecast, by Mode
      • 16.4.15.7 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 16.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.4 Taiwan Market Size and Forecast, by Application
      • 16.4.16.5 Taiwan Market Size and Forecast, by End User
      • 16.4.16.6 Taiwan Market Size and Forecast, by Mode
      • 16.4.16.7 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 16.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.4 Malaysia Market Size and Forecast, by Application
      • 16.4.17.5 Malaysia Market Size and Forecast, by End User
      • 16.4.17.6 Malaysia Market Size and Forecast, by Mode
      • 16.4.17.7 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 16.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Technology
    • 16.5.5 Latin America Market Size and Forecast, by Application
    • 16.5.6 Latin America Market Size and Forecast, by End User
    • 16.5.7 Latin America Market Size and Forecast, by Mode
    • 16.5.8 Latin America Market Size and Forecast, by Stage
    • 16.5.9 Latin America Market Size and Forecast, by Functionality
    • 16.5.10 Latin America Market Size and Forecast, by Solutions
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Technology
      • 16.5.9.4 Brazil Market Size and Forecast, by Application
      • 16.5.9.5 Brazil Market Size and Forecast, by End User
      • 16.5.9.6 Brazil Market Size and Forecast, by Mode
      • 16.5.9.7 Brazil Market Size and Forecast, by Stage
      • 16.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 16.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Technology
      • 16.5.10.4 Mexico Market Size and Forecast, by Application
      • 16.5.10.5 Mexico Market Size and Forecast, by End User
      • 16.5.10.6 Mexico Market Size and Forecast, by Mode
      • 16.5.10.7 Mexico Market Size and Forecast, by Stage
      • 16.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 16.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Technology
      • 16.5.11.4 Argentina Market Size and Forecast, by Application
      • 16.5.11.5 Argentina Market Size and Forecast, by End User
      • 16.5.11.6 Argentina Market Size and Forecast, by Mode
      • 16.5.11.7 Argentina Market Size and Forecast, by Stage
      • 16.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 16.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Mode
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Mode
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Mode
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Technology
      • 16.6.10.4 UAE Market Size and Forecast, by Application
      • 16.6.10.5 UAE Market Size and Forecast, by End User
      • 16.6.10.6 UAE Market Size and Forecast, by Mode
      • 16.6.10.7 UAE Market Size and Forecast, by Stage
      • 16.6.10.8 UAE Market Size and Forecast, by Functionality
      • 16.6.10.9 UAE Market Size and Forecast, by Solutions
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Technology
      • 16.6.11.4 South Africa Market Size and Forecast, by Application
      • 16.6.11.5 South Africa Market Size and Forecast, by End User
      • 16.6.11.6 South Africa Market Size and Forecast, by Mode
      • 16.6.11.7 South Africa Market Size and Forecast, by Stage
      • 16.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 16.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Mode
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Adaptimmune Therapeutics
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Immunocore
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Iovance Biotherapeutics
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Fate Therapeutics
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Kite Pharma
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Jounce Therapeutics
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Replimune Group
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Compugen
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Agenus
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 OncoSec Medical
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 CureVac
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Neon Therapeutics
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 BioNTech
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Tessa Therapeutics
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Argenx
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis